Molbio Diagnostics Limited will hold a board meeting on November 5, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2026, and the trading window for the company's shares remains closed from October 1, 2026, until 48 hours after the results are declared.